NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.
|
28777933 |
2017 |
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.
|
28777933 |
2017 |
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.
|
28777933 |
2017 |
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.
|
28777933 |
2017 |
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Global developmental delay
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
A recurrent de novo missense mutation in UBTF causes developmental neuroregression.
|
29300972 |
2018 |
Global developmental delay
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.
|
28777933 |
2017 |
Developmental regression
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
In seven unrelated affected individuals, all suffering from developmental regression starting at 2.5-7 years, we identified a heterozygous variant, c.628G>A in UBTF, encoding p.Glu210Lys in UBF, which occurred de novo in all cases.
|
28777933 |
2017 |
Developmental regression
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Developmental regression
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Developmental delay (disorder)
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.
|
28777933 |
2017 |
Body Fat Distribution
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of body fat distribution identifies adiposity loci and sex-specific genetic effects.
|
30664634 |
2019 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects.
|
29304378 |
2018 |
Nerve Degeneration
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
A recurrent de novo missense mutation in UBTF causes developmental neuroregression.
|
29300972 |
2018 |
Poor school performance
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
A recurrent de novo missense mutation in UBTF causes developmental neuroregression.
|
29300972 |
2018 |
Corpuscular Hemoglobin Concentration Mean
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis.
|
28017375 |
2017 |
Corpuscular Hemoglobin Concentration Mean
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
Chorea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dystonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Muscle Rigidity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle Spasticity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nerve Degeneration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|